The BREAST study aims to support female breast cancer survivors with the changes that breast cancer treatment can bring to their sexual lives. We will compare two effective treatments - a mindfullness-based treatment and sex education - in addressing difficulties with sexual desire, sexual distre

Prostate Cancer Survivorship 360º is a collaboration-based initiative involving prostate cancer (PC) and survivorship researchers/clinicians from three Canadian prostate centers with the goal of identifying and tracking unmet supportive care needs of patients with localized PC and responding to t

The Women's HARP study is a multi-center, diagnostic observational study employing standardized imaging protocols in women with MINOCA (MI with Non Obstructive Coronary Arteries) to determine the underlying diagnosis in each participant.

Target enrollment is 1000 prospectively enrolled subjects with an initial negative biopsy scheduled for repeat biopsy.

Subjects must have had their negative index prostate biopsy procedure within 30 months of being scheduled for their repeat biopsy.

The purpose of this study is to determine the benefit and safety of relugolix 120 mg once daily for 48 weeks on maintaining serum testosterone suppression to castrate levels (<=50 ng/dL [1.7 nmol/L] in patients with androgen-sensitive advanced prostate cancer.

One in eight men will be diagnosed with prostate cancer in their lifetime, and up to 90% of men who receive treatment will experience changes to their sexual functioning and their intimate lives.  We are interested in evaluating different treatment options for improving intimacy in couples after

At the Falls Prevention Clinic, each subject receives a comprehensive assessment of his or her individual risk factors for falling in addition to a comprehensive medical examination. Recommendations and appropriate followup tests and referrals are ordered for patients on an individual basis.

The purpose of this study is to determine if there are differences between patients who receive metformin or placebo with respect to the proportion of patients who meet the diagnostic criteria for metabolic syndrome after 18 months of study treatment.

This is a randomized, double-blind, placebo-controlled, multicentre, parallel-group study to assess the cognitive effects of lurasidone in bipolar I and II patients (manic depression) who are in remission from an episode.

In this study, we will examine how sexual identity (asexuality and heterosexuality) and sexual difficulties (i.e. clinically low desire) are related to the cognitive processing of sexual and non-sexual information.

The purpose of this study is to determine if treatment with androgen deprivation therapy (ADT) plus apalutamide before and after radical prostatectomy in participants with high-risk localized or locally advanced prostate cancer results in an improvement in pathological complete response (pCR) rat

The goal of the current study is to determine the prevalence, rate, and types of pregnancy complications and early life events that may be associated with the emergence of psychosis and related metabolic disorder in patients with schizophrenia spectrum disorders.

We would like to find out how women with and without sexual difficulties respond to videos and pictures, some of which contain erotic material.  More specifically, we aim to understand the neurocognitive correlates of sexual arousal and desire, including attention to sexual cues, and physiologica

The purpose of this study is to evaluate the safety and tolerability of AMG 160; a half-life extended (HLE) bispecific T-cell engager (BiTE®) antibody construct, alone and in combination with pembrolizumab in subjects with metastatic castration-resistant prostate cancer.

We would like to explore different aspects of sexual identity among individuals who self-identify as asexual, bisexual, gay, or heterosexual.

Recruitment Poster

The purpose of this study is to explore different aspects of sexuality by examining how sexual identity is related to visual processing of erotic and neutral images.

The purpose of this study is to assess the safety and efficacy of enzalutamide in patients with non metastatic prostate cancer.

The goal of this clinical research study is to learn if treatment with standard systemic therapy in combination with surgery or radiation therapy is more effective at controlling prostate cancer than standard systemic therapy alone.

The purpose of this study is to assess enzalutamide plus leuprolide in patients with high-risk nonmetastatic prostate cancer progressing after radical prostatectomy or radiotherapy or both.